UK animal genetics firm Genus surges on annual profit forecast upgrade

Core Viewpoint - British animal genetics company Genus anticipates reporting full-year adjusted pretax profit "moderately above" the upper end of current market expectations, resulting in a share price increase of up to 15.3% [1] Group 1 - Genus's expected profit performance indicates strong financial health and potential for growth in the animal genetics sector [1] - The positive market reaction, with shares rising as much as 15.3%, reflects investor confidence in Genus's future prospects [1]